Literature DB >> 8748300

Natamycin as a selective antifungal agent in media for growth of Legionella spp.

P H Edelstein1, M A Edelstein.   

Abstract

The growth of 18 different Legionella sp. strains and 76 different yeast isolates was tested on buffered charcoal yeast extract medium supplemented with alpha-ketoglutarate (BCYE alpha medium) and with natamycin, an antifungal agent. Bacterial growth was no different on BCYE alpha medium made with or without natamycin, whereas complete inhibition of yeasts occurred in BCYE alpha medium containing 200 to 500 micrograms of natamycin per ml. Selective BCYE alpha media made with natamycin rather than anisomycin had no (formulation with vancomycin, polymyxin B, and agar) or little (formulation with cefamandole, polymyxin B, and agar) inhibitory effect on the growth of 14 different Legionella sp. bacteria. Natamycin is an inexpensive alternative to anisomycin in the formulation of selective BCYE alpha media.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8748300      PMCID: PMC228757          DOI: 10.1128/jcm.34.1.185-187.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Natamycin as a fungicide in agar media.

Authors:  J C Pedersen
Journal:  Appl Environ Microbiol       Date:  1992-03       Impact factor: 4.792

2.  Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens.

Authors:  P H Edelstein
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

3.  Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium.

Authors:  P H Edelstein; M A Edelstein
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

4.  Cefamandole-susceptible strains of Legionella pneumophila serogroup 1: implications for diagnosis and utility as an epidemiological marker.

Authors:  R M Vickers; J E Stout; L S Tompkins; N J Troup; V L Yu
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

5.  Comparison of different agars used in the formulation of buffered charcoal yeast extract medium.

Authors:  P H Edelstein; M A Edelstein
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

6.  Legionella monitoring: a continuing story of nosocomial infection prevention.

Authors:  M Vincent-Houdek; H L Muytjens; G P Bongaerts; R J van Ketel
Journal:  J Hosp Infect       Date:  1993-10       Impact factor: 3.926

  6 in total
  2 in total

1.  In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.

Authors:  P H Edelstein; T Shinzato; E Doyle; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 2.  Biotechnological production and application of the antibiotic pimaricin: biosynthesis and its regulation.

Authors:  Jesús F Aparicio; Eva G Barreales; Tamara D Payero; Cláudia M Vicente; Antonio de Pedro; Javier Santos-Aberturas
Journal:  Appl Microbiol Biotechnol       Date:  2015-10-29       Impact factor: 4.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.